[A Case of Response to Pembrolizumab in Unresectable Recurrent Esophageal Cancer That Relapsed after Nivolumab Therapy]
{{output}}
The patient was a 60-year-old male who underwent subtotal esophagectomy following 3 courses of DCF therapy as preoperative adjuvant chemotherapy for advanced esophageal cancer. The surgery resulted in R2 resection. The postoperative pathology indicated MtUt, C... ...
